1News 1News: your global news briefing, coming soon on iOS & Android
Coming Soon
Back to Business
Oppenheimer reiterates Amgen stock rating on cancer drug data
Business October 25, 2026 at 11:20 PM

Oppenheimer reiterates Amgen stock rating on cancer drug data

Investing.com
Read the full story at Investing.com
More Stories
Anthropic’s Claude accessed Georgia state vote count data behind paywall
Business
Anthropic’s Claude accessed Georgia state vote count data behind paywall
🇺🇸 Investing.com 21m ago
Lula is re-elected Brazil’s president in knife-edge election
Business
Lula is re-elected Brazil’s president in knife-edge election

Victory of 80-year-old leftist over Flávio Bolsonaro is blow to Trump’s aim of greater US influence in Latin America

🇺🇸 Financial Times 28m ago
Horizon Kinetics buys Texas Pacific Land stock for $340
Business
Horizon Kinetics buys Texas Pacific Land stock for $340
🇺🇸 Investing.com 44m ago
1News
Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play